NCT00435240

Brief Summary

There is uncertainty about the optimal diet in the prevention and treatment of diabetes type 2. Earlier studies have generally focused on intakes of fat, protein, carbohydrate, fiber, fruit and vegetables. This study is based on another approach which compares foods that were available during human evolution with more recently introduced ones. The basic tenet from evolutionary biology is that if human physiology is less adapted to a relatively recently introduced diet based on agriculture, this could cause disturbances to human physiology and ultimately lead to diseases. Epidemiological studies indicates that diabetes mellitus type 2 is absent or near absent in populations eating a Palaeolithic ("Old Stone Age") diet which is free from food items produced in agriculture or the food industry. Our study hypothesis is that a Palaeolithic diet is better than the standard diabetes diet recommended today in treating diabetes type 2. Fifteen patients with diabetes type 2 have been randomized to

  1. 1.a Palaeolithic diet based on lean meat, fish, fruit, vegetables, root vegetables, eggs, and nuts
  2. 2.a standard diabetes diet as recommended by national health authorities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for phase_2 diabetes-mellitus-type-2

Timeline
Completed

Started Jan 2005

Longer than P75 for phase_2 diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 13, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 14, 2007

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2007

Completed
Last Updated

May 15, 2008

Status Verified

May 1, 2008

Enrollment Period

2.7 years

First QC Date

February 13, 2007

Last Update Submit

May 13, 2008

Conditions

Outcome Measures

Primary Outcomes (5)

  • area under the curve for glucose (AUC Glucose0-120) at the oral glucose tolerance test at baseline, 3 months and 6 months

  • area under the curve for insulin (AUC Insulin0-120) at the oral glucose tolerance test at baseline, 3 months and 6 months

  • HbA1C at baseline, 3 months and 6 months

  • weight at baseline, 3 months and 6 months

  • waist circumference at baseline, 3 months and 6 months

Secondary Outcomes (7)

  • satiation measured on visual semi-analogous scale at food intake during 4 days av 6 weeks and 12 weeks

  • leptin at baseline, 3 months and 6 months

  • fasting plasma glucose at baseline, 3 months and 6 months

  • fasting plasma insulin at baseline, 3 months and 6 months

  • Systolic and diastolic blod pressure at baseline, 3 months and 6 months

  • +2 more secondary outcomes

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with capacity to perform study
  • Diabetes Mellitus Type 2
  • C-peptide \> 0
  • HbA1C \>5.5
  • Unchanged diabetes treatment during last 3 months
  • Weight and HbA1C varied less than 5% during last 3 months
  • No acute heart disease during last 6 months
  • Unchanged treatment with betablocker last 6 months
  • Unchanged treatment with thyroid hormone substitution last 6 months

You may not qualify if:

  • Treatment with insulin
  • Chronic treatment with steroids (not inhaled)
  • Treatment with Waran (anticoagulant cumarin type)
  • Creatinin \> 130 micromol/L
  • Elevated liver enzymes (ALAT,ASAT,ALP or GT \> 4 X upper reference value)
  • Acute heart disease
  • Changed treatment with betablocker or thyroid hormone substitution

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lund University Hospital

Lund, Skåne County, 22185, Sweden

Location

Related Publications (6)

  • Jonsson T, Ahren B, Pacini G, Sundler F, Wierup N, Steen S, Sjoberg T, Ugander M, Frostegard J, Goransson L, Lindeberg S. A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr Metab (Lond). 2006 Nov 2;3:39. doi: 10.1186/1743-7075-3-39.

    PMID: 17081292BACKGROUND
  • Jonsson T, Olsson S, Ahren B, Bog-Hansen TC, Dole A, Lindeberg S. Agrarian diet and diseases of affluence--do evolutionary novel dietary lectins cause leptin resistance? BMC Endocr Disord. 2005 Dec 10;5:10. doi: 10.1186/1472-6823-5-10.

    PMID: 16336696BACKGROUND
  • Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005 Feb;81(2):341-54. doi: 10.1093/ajcn.81.2.341.

    PMID: 15699220BACKGROUND
  • Fontes-Villalba M, Granfeldt Y, Sundquist K, Memon AA, Hedelius A, Carrera-Bastos P, Jonsson T. Effects of a Paleolithic diet compared to a diabetes diet on leptin binding inhibition in secondary analysis of a randomised cross-over study. BMC Endocr Disord. 2024 Sep 4;24(1):176. doi: 10.1186/s12902-024-01715-0.

  • Fontes-Villalba M, Lindeberg S, Granfeldt Y, Knop FK, Memon AA, Carrera-Bastos P, Picazo O, Chanrai M, Sunquist J, Sundquist K, Jonsson T. Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial. Cardiovasc Diabetol. 2016 May 23;15:80. doi: 10.1186/s12933-016-0398-1.

  • Jonsson T, Granfeldt Y, Ahren B, Branell UC, Palsson G, Hansson A, Soderstrom M, Lindeberg S. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol. 2009 Jul 16;8:35. doi: 10.1186/1475-2840-8-35.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Diet, Paleolithic

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Tommy Jönsson, MD

    Department of Clinical Sciences, Lund University, Lund Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 13, 2007

First Posted

February 14, 2007

Study Start

January 1, 2005

Primary Completion

September 1, 2007

Study Completion

September 1, 2007

Last Updated

May 15, 2008

Record last verified: 2008-05

Locations